Gilead Sciences, Inc. GILD
Nov 12, 2026, 10:30 AM EST
- YTD
- +38.31%
- 1 year
- +37.57%
Discussion (349)
Sign in to join the discussion
$GILD Oppenheimer started coverage on Gilead Sciences in a research note on Monday, June 28th. They issued a "buy" rating and a $100.00 target price on the stock. Jefferies Financial Group reissued a "buy" rating and issued a $80.00 price target on shares of Gilead Sciences in a report on Friday, May 7th. Morgan Stanley boosted their target price on Gilead Sciences from $81.00 to $83.00 and gave the company an "overweight" rating in a research note on Monday
Gilead has to get into CRISPR. Check out CRBU patents https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&f=S&l=50&d=PTXT&RS=AN%2FCaribou&Refine=Refine+Search&Query=AN%2FCaribou+AND+Biosciences
$GILD Come on bitch. Close over $70
$GILD Company Executives need to be higher profile. Get out there and do some press on the company! Lots to talk about. Stop being a boring suit!
$GILD 70’s soon! ???
$GILD Wall Street brokerages forecast that Gilead Sciences, Inc. (NASDAQ:GILD) will post $6.15 billion in sales for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Gilead Sciences' earnings. The lowest sales estimate is $6.02 billion and the highest is $6.27 billion. Gilead Sciences posted sales of $5.14 billion during the same quarter last year, which suggests a positive year over year growth rate of 19.6%.
25 million worth of calls placed today nice ?
zafar KAZMI GILD 5 years ago #59$GILD Some dammed lousy company. I had been stuck into it for more than one year & finally got out of it today taking some hit in a little over 10k. Thank goodness. I’m out!!!
zafar KAZMI GILD 5 years ago #60$GILD High sure smoking some good stuff,